Skip to content
OpenCapital
Get started

Journey Medical Corporation DERM Emrosi — Revenue

Other product segments

Qbrexza
$5.03M-2.6%
Accutane
$3.31M-9.3%
Foam Franchise Products Amzeeq Zilxi
$1.05M—
Other Legacy
$277K-61.9%

Similar metrics at other companies

EyePoint, Inc. logo
EYPTProduct — Revenue
$500K-30.1%
Nuvation Bio logo
NUVBProduct Revenue — Revenue
$18.5M+2,213%
Ocular Therapeutix logo
OCULProduct — Revenue
$10.79M+1.4%
LQD
LQDAProduct — Revenue
$129.88M—
PTC Therapeutics logo
PTCTProduct — Revenue
$225.57M+47.0%
Avanos Medical logo
AVNSRevenue
$182.2M+8.8%

Other financials

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%
CapEx$3.8M—
Free cash flow-$6.0M—

Valuation

See full
Market cap$194.94M+20.9%
Enterprise value$193.19M+16.2%
P/S3×+0.2×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%—
Net margin-14.8%—
FCF margin-43%—

Returns & leverage

See full
Return on equity-36.6%—
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by Journey Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's emrosi — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Journey Medical Corporation's emrosi — revenue?
Journey Medical Corporation (DERM) reported emrosi — revenue of $6.25M in Q1 2026.
How has Journey Medical Corporation's emrosi — revenue changed year-over-year?
Journey Medical Corporation's emrosi — revenue increased by 202.0% year-over-year, from $2.07M to $6.25M.
What does emrosi — revenue mean?
This metric represents the total gross revenue generated from the sale of the Emrosi pharmaceutical product, net of any assessed taxes. It serves as a primary indicator of the product's market adoption, commercial performance, and contribution to the company's overall top-line growth within the dermatology portfolio. Tracking this figure allows investors to evaluate the specific demand for this therapeutic offering and its role in the company's revenue diversification strategy.